RecruitingNot ApplicableNCT07378072

Efficacy of 12-week Daytime Restricted Eating on Hepatic Steatosis of Obesity

Efficacy of 12-week Daytime Restricted Eating on Hepatic Steatosis of Obesity: Randomized, Open-label, Parallel Group, Controlled Superiority Trial _ CHRONOSTEATOSIS


Sponsor

Nantes University Hospital

Enrollment

72 participants

Start Date

Jun 17, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

The objective of this study is to demonstrate that an \< or equal to 8-hour time-restricted eating (i.e., fasting for at least 16 hours every day), not focusing on reducing caloric intake, reduces intra-hepatic fat in patients with obesity and Metabolic dysfunction-Associated Steatotic liver Disease (MASLD).


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a behavioral approach called Time Restricted Eating and a behavioral approach called Usual care only for people with masld - metabolic dysfunction-associated steatotic liver disease. The study is currently recruiting participants at 9 locations. People eligible for this study include aged 18 Years to 65 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALTime Restricted Eating

Coaching of the patient by a dietetician for reduction of time of daily food intake to a window of 8 hours per day or less and thus increase of daily fasting to at least 16 hours, in addition to usual dietary counselling to achieve a balanced diet (no calorie restriction) and increase physicial activity as recommended (current guidelines).

BEHAVIORALUsual care only

Usual care: dietary counselling to achieve a balanced diet (no calorie restriction) and increase physicial activity as recommended (current guidelines).


Locations(9)

CHU Angers

Angers, France

CHU Bordeaux

Bordeaux, France

CHU Dijon-Bourgogne

Dijon, France

CHU Lyon

Lyon, France

CHU Marseille

Marseille, France

CHU Montpellier

Montpellier, France

CHU Nantes

Nantes, France

Hôpital Européen Georges Pompidou

Paris, France

CHU Rennes

Rennes, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07378072


Related Trials